
Patricia Callahan
I’m a Pulitzer Prize-winning investigative reporter exploring how federal policies affect the health of vulnerable people.
Have a Tip for a Story?
What I Cover
I’m reporting on the Centers for Disease Control and Prevention as it grapples with cuts in staff and funding and a new administration determined to end longstanding global health programs and collaboration.
My Background
For more than three decades, my stories about health and safety have prompted changes in laws and saved lives.
During the COVID-19 pandemic, ProPublica colleagues and I explored the anguish inside the CDC as, with breathtaking speed, the vaunted agency — the global gold standard for public health — became a target of anger, scorn and even pity. Many reporters had covered clashes between the first Trump administration and the agency’s scientists. But we wanted to tell a story that was more intimate and consequential: What happened when the CDC lost the public’s trust? What was it like for scientists ordered to go along with directives that ran counter to everything they believed? Our investigative narrative took readers inside as some employees rebelled and others acquiesced. We showed how this loss of trust could have serious repercussions, influencing whether people decide to get vaccinated or reflexively reject any recommendations from public health officials. Subsequent Congressional hearings drew heavily on our reporting, and the story was a centerpiece of the ProPublica pandemic coverage that was named a finalist for a Pulitzer Prize.
I joined ProPublica in 2018 after many years as a reporter on the Chicago Tribune’s investigative team. There I revealed how the U.S. Consumer Product Safety Commission, with its myopic and docile approach to regulation, failed to protect children from injuries and death. This series, reported with my Tribune colleagues, prompted the biggest overhaul of product safety regulations in a generation, led to the recall of millions of toys and cribs and won a Pulitzer Prize.
My colleagues and I also exposed deceptive campaigns by the chemical and tobacco industries that brought toxic flame retardants into our homes and our bodies even though these harmful compounds don’t protect us from fires. The series led to a repeal of the rule responsible for the flame retardants packed into American furniture and was a finalist for a Pulitzer Prize. My reporting was featured in two films, “Merchants of Doubt” and “Toxic Hot Seat.”
In addition, we showed how Illinois state officials steered low-income adults with developmental and intellectual disabilities into less-expensive, privately run group homes, then hid the resulting harm and deaths. That series, too, was a finalist for the Pulitzer Prize.
Earlier in my career, I was a lead reporter on the Denver Post team that won a Pulitzer Prize for coverage of the Columbine High School massacre.
I graduated from Northwestern University’s Medill School of Journalism and was a Henry Luce Scholar in Thailand.
I read my mail! If you want to send a tip or documents that way, here’s my address:
Patricia Callahan
ProPublica
155 Avenue of the Americas, 13th Floor
New York, NY 10013
How Peter Thiel Turned a Retirement Account for the Middle Class Into a Tax-Free Piggy Bank
Roth IRAs were intended to help average working Americans save, but IRS records show Thiel and other ultrawealthy investors have used them to amass vast untaxed fortunes.
by Justin Elliott, Patricia Callahan and James Bandler,
CDC Shut Down a Lab Involved in Making Faulty Coronavirus Tests
A CDC lab involved in making faulty coronavirus tests sent to state and local officials early in the pandemic was closed down hours after an October investigation by ProPublica exposed key mistakes the CDC made in manufacturing those tests.
Congressional Investigation Finds Many Booster Seat Makers “Endangered” Children’s Lives After Review of “Meaningless Safety Testing”
The congressional subcommittee launched its inquiry in response to a ProPublica investigation, finding several companies created tests that were “nearly impossible to fail.” Now it’s asking state and federal regulators to investigate too.
House Subcommittee Says Proposed Booster Seat Safety Rules Fall Short
Following a ProPublica investigation, members of Congress say “unsafe” booster seats are being sold to parents while regulators fail to protect children.
The Trump Administration Is Backing Out of a $647 Million Ventilator Deal After ProPublica Investigated the Price
The government overpaid by hundreds of millions for Philips ventilators, says a House investigation spurred by ProPublica reporting. Now that deal is off and Congress is scrutinizing other coronavirus deals made by trade adviser Peter Navarro.
by Patricia Callahan and Sebastian Rotella,
The White House Paid Up to $500 Million Too Much for Ventilators, Congressional Investigators Say
A House panel says “gullible” White House negotiators overpaid for Phillips ventilators, and it has asked the Department of Health and Human Services Office of Inspector General to investigate evidence of fraud in the deal.
by Patricia Callahan and Sebastian Rotella,
Inside the Trump Administration’s Decision to Leave the World Health Organization
Despite Trump’s declared exit from the WHO, officials continued working toward reforms and to prevent withdrawal. This week, they were told they must justify any cooperation with the WHO on the grounds of national security and public health safety.
Congress Is Investigating Whether a Ventilator Company Is Gouging the U.S. — and Why the Government Is Letting It Happen
A congressional subcommittee is questioning a federal decision to pay quadruple the price for the commercial version of a ventilator Royal Philips N.V. had developed with taxpayer funds.
by Patricia Callahan and Sebastian Rotella,
A Company Promised Cheap Ventilators to the Government, Never Delivered and Is Now Charging Quadruple the Price for New Ones
Royal Philips N.V. agreed in September to sell 10,000 ventilators to the U.S. for $3,280 each. It did not deliver. But the Dutch company just announced a new deal with the government. This time, it’s charging roughly $15,000 each.
by Patricia Callahan and Sebastian Rotella,
Taxpayers Paid Millions to Design a Low-Cost Ventilator for a Pandemic. Instead, the Company Is Selling Versions of It Overseas.
As coronavirus sweeps the globe, there is not a single Trilogy Evo Universal ventilator — developed with government funds — in the U.S. stockpile. Meanwhile, Royal Philips N.V. has sold higher-priced versions to clients around the world.
by Patricia Callahan, Sebastian Rotella and Tim Golden,